ライフサイエンスコーパス: test battery

1 o Establish a Registry for Alzheimer Disease test battery.

2 assessed with a detailed neuropsychological test battery.

3 inst a gold standard neuropsychological (NP) test battery.

4 negative facial expressions in an emotional test battery.

5 mentia was evaluated with neuropsychological test battery.

6 stimuli during performance of the Emotional Test Battery.

7 utive function were derived from a cognitive test battery.

8 ividuals by using a comprehensive laboratory test battery.

9 s assessed by using a computerized cognitive test battery.

10 ning tasks and a detailed neuropsychological test battery.

11 administered computerized neuropsychological test battery.

12 ng blood draw and a brief neuropsychological test battery.

13 Patients also completed a neuropsychological test battery.

14 CN mutant mice to a comprehensive behavioral test battery.

15 rld Health Organization Neurobehavioral Core Test Battery.

16 ia completed an extensive neuropsychological test battery.

17 pairs, on a comprehensive neuropsychological test battery.

18 d daily on a computerized neuropsychological test battery.

19 groups on the audiological component of the test battery.

20 (n = 177), they completed cognitive ability test batteries.

21 ividuals' aggregate performance in cognitive test batteries [1-9].

22 re, we utilized a modified Primate Cognitive Test Battery [13] in conjunction with quantitative genet

23 From the entire neuropsychological test battery, a stepwise selection procedure retained 2

24 nsgenic (NT) mice in an extensive behavioral test battery administered between 5 and 8.5 months of ag

25 s in the performance of animals on cognitive test batteries analogous to those of humans?

26 ted using a comprehensive neuropsychological test battery and a derived measure from the Heinrichs-Ca

27 th groups were administered a neurocognitive test battery and a standardized RCC measure (Capacity to

28 cterise cognitive domains underlying a large test battery and for the first time, evaluate their abil

29 h participant completed a neuropsychological test battery and had clinical cognitive status (dementia

30 he authors administered a neuropsychological test battery and temperament questionnaires to samples o

31 ects completed a detailed neuropsychological test battery and were classified as impaired or unimpair

32 ophrenia completed a comprehensive cognitive test battery and were rated on symptom measures at index

33 and PHES were compared using a computerized test battery and West Haven criteria as reference.

34 findings to performance on a neurocognitive test battery, and found that N-acetylaspartylglutamate (

35 inistered a comprehensive neuropsychological test battery, and neurological signs were assessed with

36 Many neuropsychological test batteries are comprehensive and require specialized

37 Current test batteries are either limited in scope or are of an

38 Validated test batteries are now available that may prove to be of

39 mal control subjects on a neuropsychological test battery assessing a range of cognitive domains.

40 cedures comprise part of a wider touchscreen test battery assessing cognition in rodents with high po

41 A cognitive test battery assessing memory, attention, language, visu

42 completed a comprehensive neuropsychological test battery at baseline and again at an 8-week follow-u

43 been adapted from a human neuropsychological testing battery (CANTAB, Cambridge Cognition, Ltd) for u

44 headache questionnaires, neuropsychological test battery, combat exposure and alcohol use surveys, a

45 The study patients were given a test battery consisting of a questionnaire specific for

46 ent Metrics (ANAM), a computerized cognitive testing battery consisting of cognitive subtests, a slee

47 us, processing these chemicals using current test batteries could require millions of dollars and dec

48 ht result from procedural inconsistencies in test battery design, but also from differences in how an

49 linical Global Impression (CGI) scale, and a test battery designed to measure cognitive function in p

50 velopment Study completed the novel "Bricks" test battery, designed to tap these abilities in isolati

51 ndicators of efficacy, such as the Emotional Test Battery, EEG markers, and fMRI correlates of anhedo

52 were administered a full neuropsychological test battery for cognitive performance.

53 can thus be used as part of a comprehensive test battery for learning and memory in this species.

54 d elsewhere) was assessed using an extensive test battery; global cognitive functioning as assessed b

55 on and followed by a mask, and the Emotional Test Battery in which reaction times and performance acc

56 A neurocognitive test battery included domain-specific assessments of lea

57 A cognitive test battery included the Kendrick Object Learning Test,

58 toxicity findings using the current in vitro testing battery is a major challenge to industry and reg

59 search assistants using a neuropsychological test battery measuring simple and complex attention, pro

60 A cognitive test battery modeled after the one used in the Women's H

61 endpoint was change in a neuropsychological test battery (NTB) score.

62 cally assessed using the computer-aided TAP (Test Battery of Attentional Performance).

63 administered an extensive neuropsychological test battery organized into the following 5 functions: a

64 During the Emotional Test Battery, reaction times decreased to identification

65 nd patients completed the neuropsychological test battery recommended by the ACR, the Center for Epid

66 verbal and math abilities, with a variety of test batteries scheduled at different time points in the

67 measured by a decrease in neuropsychological test battery scores (Mini-Mental State Examination, Lett

68 In the cognitive test battery, subjects in the xanomeline group showed im

69 bjects on a comprehensive neuropsychological test battery that assessed cognitive function.

70 and female wild-type and GluR-A-/- mice on a test battery that assessed sensorimotor, affective, and

71 All subjects underwent a neuropsychological test battery that included tasks found to be sensitive t

72 section for tumour or epilepsy), utilizing a test battery that is sensitive to semantic impairment in

73 ugh the use of a computerized neurocognitive test battery that provided measures of accuracy and spee

74 When tested on multiple test batteries, the overall performance ranks of individ

75 and 28, we administered a neuropsychological test battery to assess general intellectual function, ab

76 luences psychosocial outcomes, (3) the ideal test battery to assess the psychosocial benefits of grou

77 The authors used a neuropsychological test battery to characterize the neuropsychiatric profil

78 Hg <4 microg/l), applying a neurobehavioral test battery to evaluate CNS functions in relation to bo

79 We used a comprehensive neuropsychological test battery to evaluate cognitive function longitudinal

80 o 60 years) were administered a standardized testing battery to assess cardiovascular reactivity to m

81 m the Cambridge Automated Neuropsychological Test Battery (Tower of London, spatial working memory, i

82 A test battery using sensory psychophysics, psychometric t

83 A test battery was administered that comprised three sets

84 A neuropsychological test battery was administered to patients with a diagnos

85 An extensive neuropsychological test battery was administered, and multivariate analysis

86 and finds that others for which the original test battery was inconclusive are not actually significa

87 A behavioral test battery was used to assess anxiety-like, depressive

88 A neuropsychological test battery was used to assess cognition.

89 A neurocognitive test battery was used to assess speed of processing, att